242 related articles for article (PubMed ID: 26117492)
1. Omalizumab therapy for refractory allergic fungal rhinosinusitis patients with moderate or severe asthma.
Gan EC; Habib AR; Rajwani A; Javer AR
Am J Otolaryngol; 2015; 36(5):672-7. PubMed ID: 26117492
[TBL] [Abstract][Full Text] [Related]
2. Omalizumab versus intranasal steroids in the post-operative management of patients with allergic fungal rhinosinusitis.
Mostafa BE; Fadel M; Mohammed MA; Hamdi TAH; Askoura AM
Eur Arch Otorhinolaryngol; 2020 Jan; 277(1):121-128. PubMed ID: 31552526
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of pressure-induced cranial neuropathies from allergic fungal rhinosinusitis.
Illing EA; Dunlap Q; Woodworth BA
Otolaryngol Head Neck Surg; 2015 Mar; 152(3):541-5. PubMed ID: 25583853
[TBL] [Abstract][Full Text] [Related]
4. Omalizumab Treatment in Uncontrolled Asthma and CRSwNP Patients, with Previous Endoscopic Sinus Surgery, to Improve Quality of Life and Endoscopic Outcomes: a Two-Year Real-Life Study.
Maza-Solano J; Callejon-Leblic A; Martin-Jimenez D; Moreno-Luna R; Gonzalez-Garcia J; Cuvillo A; Sanchez-Gomez S
Curr Allergy Asthma Rep; 2023 Oct; 23(10):555-566. PubMed ID: 37644255
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of preoperative itraconazole in allergic fungal rhinosinusitis.
Patro SK; Verma RK; Panda NK; Chakrabarti A; Singh P
Am J Rhinol Allergy; 2015; 29(4):299-304. PubMed ID: 26163250
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of itraconazole in the management of refractory allergic fungal rhinosinusitis.
Chan KO; Genoway KA; Javer AR
J Otolaryngol Head Neck Surg; 2008 Dec; 37(6):870-4. PubMed ID: 19128719
[TBL] [Abstract][Full Text] [Related]
7. Long-term omalizumab efficacy in allergic rhinitis.
Cavaliere C; Begvarfaj E; Incorvaia C; Sposato B; Brunori M; Ciofalo A; Greco A; de Vincentiis M; Masieri S
Immunol Lett; 2020 Nov; 227():81-87. PubMed ID: 32798500
[TBL] [Abstract][Full Text] [Related]
8. Allergic Fungal Rhinosinusitis and the Unified Airway: the Role of Antifungal Therapy in AFRS.
Ryan MW; Clark CM
Curr Allergy Asthma Rep; 2015 Dec; 15(12):75. PubMed ID: 26515449
[TBL] [Abstract][Full Text] [Related]
9. Omalizumab treats chronic rhinosinusitis with nasal polyps and asthma together-a real life study.
Bidder T; Sahota J; Rennie C; Lund VJ; Robinson DS; Kariyawasam HH
Rhinology; 2018 Mar; 56(1):42-45. PubMed ID: 29288573
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the clinical features and laboratory data of patients with severe asthma classified as super-responder or non super-responder to omalizumab treatment: a single-center real-life study.
Cakmak ME; Öztop N; Yeğit OO; Özdedeoğlu Ö
J Asthma; 2023 Oct; 60(10):1862-1868. PubMed ID: 36971065
[TBL] [Abstract][Full Text] [Related]
11. Quality of life improvement from sinus surgery in chronic rhinosinusitis patients with asthma and nasal polyps.
Zhang Z; Adappa ND; Doghramji LJ; Chiu AG; Lautenbach E; Cohen NA; Palmer JN
Int Forum Allergy Rhinol; 2014 Nov; 4(11):885-92. PubMed ID: 25256422
[TBL] [Abstract][Full Text] [Related]
12. Assessment of long-term omalizumab treatment in patients with severe allergic asthma long-term omalizumab treatment in severe asthma.
Özgür ES; Özge C; Ïlvan A; Naycı SA
J Asthma; 2013 Aug; 50(6):687-94. PubMed ID: 23557459
[TBL] [Abstract][Full Text] [Related]
13. Effect of omalizumab on the need for rescue systemic corticosteroid treatment in patients with moderate-to-severe persistent IgE-mediated allergic asthma: a pooled analysis.
Busse WW; Massanari M; Kianifard F; Geba GP
Curr Med Res Opin; 2007 Oct; 23(10):2379-86. PubMed ID: 17711616
[TBL] [Abstract][Full Text] [Related]
14. Omalizumab reduces corticosteroid use in patients with severe allergic asthma: real-life experience in Israel.
Rottem M
J Asthma; 2012 Feb; 49(1):78-82. PubMed ID: 22149205
[TBL] [Abstract][Full Text] [Related]
15. Medical management of allergic fungal rhinosinusitis following endoscopic sinus surgery: an evidence-based review and recommendations.
Gan EC; Thamboo A; Rudmik L; Hwang PH; Ferguson BJ; Javer AR
Int Forum Allergy Rhinol; 2014 Sep; 4(9):702-15. PubMed ID: 25044729
[TBL] [Abstract][Full Text] [Related]
16. Qualitative effects of omalizumab on concomitant IgE-mediated disease in a severe asthmatic population: a real life observational study.
Cusack RP; Sahadevan A; Lane SJ
QJM; 2016 Sep; 109(9):601-4. PubMed ID: 26966102
[TBL] [Abstract][Full Text] [Related]
17. Systemic reaction rates with omalizumab, subcutaneous immunotherapy, and combination therapy in children with allergic asthma.
Har D; Lee MJ
Allergy Asthma Proc; 2019 Jan; 40(1):35-40. PubMed ID: 30582494
[No Abstract] [Full Text] [Related]
18. Effectiveness of Omalizumab in Severe Allergic Asthma and Nasal Polyposis: A Real-Life Study.
Tiotiu A; Oster JP; Roux PR; Nguyen Thi PL; Peiffer G; Bonniaud P; Dalphin JC; de Blay F
J Investig Allergol Clin Immunol; 2020; 30(1):49-57. PubMed ID: 30931917
[TBL] [Abstract][Full Text] [Related]
19. Omalizumab in the treatment of allergic bronchopulmonary aspergillosis: One center's experience with 14 cases.
Aydın Ö; Sözener ZÇ; Soyyiğit Ş; Kendirlinan R; Gençtürk Z; Mısırlıgil Z; Mungan D; Sin BA; Demirel YS; Çelik GE; Bavbek S
Allergy Asthma Proc; 2015; 36(6):493-500. PubMed ID: 26534756
[TBL] [Abstract][Full Text] [Related]
20. Role of preoperative versus postoperative itraconazole in allergic fungal rhinosinusitis.
Verma RK; Patro SK; Francis AA; Panda NK; Chakrabarti A; Singh P
Med Mycol; 2017 Aug; 55(6):614-623. PubMed ID: 27838640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
